arrow
I

Ioanna Sakellari

general hospital george papanikolaou
H指数:26
被引数:2,798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

更正:异基因造血干细胞移植后的继发性自身免疫性和炎症性疾病:来自EBMT移植并发症和自身免疫性疾病工作组的事后研究

2026-09-250
PRE
Nationwide Multicenter Real-World Survey of CAR-T Cell Toxicity Prophylactic and Treatment Management Strategies

全国多中心真实世界CAR-T细胞毒性预防及治疗管理策略调查

BLOOD
IF23.1
2024-11-050
PRE
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients

可溶性尿激酶型纤溶酶原激活剂受体(suPAR)和生长分化因子-15(GDF-15)水平与CAR-T细胞受体受者的内皮损伤指标显著相关。

BLOOD
IF23.1
2024-11-050
PRE
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
2024-07-260
OAAI
Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

在接受来自无关或不匹配的相关供体的异基因造血细胞移植的慢性粒细胞白血病患者中,移植后环磷酰胺预防移植物抗宿主病: 来自EBMT慢性恶性肿瘤工作组 (cmwp-ebmt) 的比较研究

2024-01-011
OAAI
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data
2023-10-115
OAAI
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

SARS-CoV-2-specific T细胞治疗严重COVID-19: 一项随机1/2期临床试验

2023-07-1718
PRE
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
2023-02-084
OAAI
Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece
2022-11-104
OAAI
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
2022-06-108
OAAI
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies

Treosulfan联合氟达拉滨在老年或合并髓系恶性肿瘤患者异基因造血干细胞移植前的生存优势

2021-11-017
OAAI